Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.

Schmauss C, Haroutunian V, Davis KL, Davidson M.

Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8942-6.

2.

The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches.

Griffon N, Sokoloff P, Diaz J, Lévesque D, Sautel F, Schwartz JC, Simon P, Costentin J, Garrido F, Mann A, et al.

Eur Neuropsychopharmacol. 1995;5 Suppl:3-9. Review.

PMID:
8775753
3.

Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.

Jardemark K, Wadenberg ML, Grillner P, Svensson TH.

Curr Opin Investig Drugs. 2002 Jan;3(1):101-5. Review.

PMID:
12054059
4.

Localization and function of the D3 dopamine receptor.

Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC.

Arzneimittelforschung. 1992 Feb;42(2A):224-30. Review.

PMID:
1586393
5.

Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders.

Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE, Mufson EJ, Che S.

Neurochem Res. 2004 Jun;29(6):1053-64. Review.

PMID:
15176463

Supplemental Content

Support Center